License Of Four Pharma Firms Cancelled For Illegal Drug Trade In Jammu & Kashmir

The license of four pharmaceutical firms have been cancelled after they were allegedly found indulging in ‘clandestine purchase and sale’ of addictive drugs in Jammu and Kashmir, an official said on Saturday.

State Drugs Controller-cum-Licensing Authority Lotika Khajuria ordered enforcement action against Healthways Pharma, Rajouri, Nuegene Pharmaceutical Distributors and NT Traders of Baramulla and Essence Pharmaceutical Distributors of Srinagar, following inspection of the wholesale firms, an official spokesperson said.

During the inspections, he said the four pharma establishments were found indulging in clandestine purchase and sale of habit-forming pharmaceutical preparations, mainly Tapentadol and Pregabalin from neighbouring states without maintaining mandatory sale or purchase records.

The spokesperson said the action against the firms reflects the department’s commitment to public health and safety and its firm resolve to prevent drug misuse, especially among vulnerable populations.

Any act that contributes to drug misuse or circumvents the law will be met with the strongest possible action, he said.

The public at large is requested to report any incidence of unethical practices involving sale or misuse of prescription drugs to the department’s helpline, the spokesperson said.

  • Related Posts

    Delhi Crime Branch Seizes Huge Stock Of Expired Baby Food, Cosmetics; One Arrested

    New Delhi: In a major crackdown on the sale of expired and substandard products, the Central Range team of Delhi Police Crime Branch has arrested one person and seized nearly…

    FDA Releases Draft Guidance To Validate Non-Animal Testing Methods (NAMs) In Drug Development

    Washington:  On March 18, 2026, the U.S. Food and Drug Administration (FDA) issued a draft guidance titled General Considerations for the Use of New Approach Methodologies in Drug Development. The…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Delhi Crime Branch Seizes Huge Stock Of Expired Baby Food, Cosmetics; One Arrested

    Delhi Crime Branch Seizes Huge Stock Of Expired Baby Food, Cosmetics; One Arrested

    FDA Releases Draft Guidance To Validate Non-Animal Testing Methods (NAMs) In Drug Development

    FDA Releases Draft Guidance To Validate Non-Animal Testing Methods (NAMs) In Drug Development

    IPC releases draft NFI-2026 to promote rational use of medicines

    IPC releases draft NFI-2026 to promote rational use of medicines

    Moonshot, SS Innovations displayed Battle Readiness for Monumental Goals in Robotic Surgery

    Moonshot, SS Innovations displayed Battle Readiness for Monumental Goals in Robotic Surgery

    US market to dent India pharma earnings even as domestic growth remains firm

    US market to dent India pharma earnings even as domestic growth remains firm

    Biocon Pharma receives USFDA approval for Dapagliflozin Tablets, 5 mg and 10 mg

    Biocon Pharma receives USFDA approval for Dapagliflozin Tablets, 5 mg and 10 mg